Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash to Debt No Debt
ZLTQ's Cash to Debt is ranked higher than
82% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. ZLTQ: No Debt )
ZLTQ' s 10-Year Cash to Debt Range
Min: 6.45   Max: No Debt
Current: No Debt

Equity to Asset 0.70
ZLTQ's Equity to Asset is ranked higher than
76% of the 373 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. ZLTQ: 0.70 )
ZLTQ' s 10-Year Equity to Asset Range
Min: -5.35   Max: 0.89
Current: 0.7

-5.35
0.89
Interest Coverage No Debt
ZLTQ's Interest Coverage is ranked higher than
77% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 81.00 vs. ZLTQ: No Debt )
ZLTQ' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: 17.96
M-Score: -2.30
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -17.33
ZLTQ's Operating margin (%) is ranked higher than
54% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 6.50 vs. ZLTQ: -17.33 )
ZLTQ' s 10-Year Operating margin (%) Range
Min: -1082.23   Max: -12.76
Current: -17.33

-1082.23
-12.76
Net-margin (%) -17.29
ZLTQ's Net-margin (%) is ranked higher than
55% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 4.71 vs. ZLTQ: -17.29 )
ZLTQ' s 10-Year Net-margin (%) Range
Min: -1111.78   Max: -14.09
Current: -17.29

-1111.78
-14.09
ROE (%) -30.85
ZLTQ's ROE (%) is ranked higher than
53% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 5.57 vs. ZLTQ: -30.85 )
ZLTQ' s 10-Year ROE (%) Range
Min: -41.53   Max: -10.18
Current: -30.85

-41.53
-10.18
ROA (%) -21.92
ZLTQ's ROA (%) is ranked higher than
53% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 3.23 vs. ZLTQ: -21.92 )
ZLTQ' s 10-Year ROA (%) Range
Min: -254.68   Max: -9.06
Current: -21.92

-254.68
-9.06
ROC (Joel Greenblatt) (%) -896.57
ZLTQ's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 12.89 vs. ZLTQ: -896.57 )
ZLTQ' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1431.25   Max: -330.43
Current: -896.57

-1431.25
-330.43
» ZLTQ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

ZLTQ Guru Trades in Q3 2013

Chuck Royce 553,200 sh (-27.69%)
» More
Q4 2013

ZLTQ Guru Trades in Q4 2013

Jim Simons 364,357 sh (New)
RS Investment Management 978,900 sh (New)
Chuck Royce 410,200 sh (-25.85%)
» More
Q1 2014

ZLTQ Guru Trades in Q1 2014

Steven Cohen 481,900 sh (New)
RS Investment Management 1,165,400 sh (+19.05%)
Chuck Royce Sold Out
Jim Simons 67,400 sh (-81.5%)
» More
Q2 2014

ZLTQ Guru Trades in Q2 2014

RS Investment Management 1,348,166 sh (+15.68%)
Steven Cohen 577,600 sh (unchged)
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with ZLTQ

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 12.89
ZLTQ's P/B is ranked lower than
68% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. ZLTQ: 12.89 )
ZLTQ' s 10-Year P/B Range
Min: 1.79   Max: 13.07
Current: 12.89

1.79
13.07
P/S 5.56
ZLTQ's P/S is ranked lower than
54% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 3.21 vs. ZLTQ: 5.56 )
ZLTQ' s 10-Year P/S Range
Min: 0.17   Max: 7.17
Current: 5.56

0.17
7.17
EV-to-EBIT -59.43
ZLTQ's EV-to-EBIT is ranked higher than
62% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 57.01 vs. ZLTQ: -59.43 )
ZLTQ' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -59.43

Current Ratio 2.87
ZLTQ's Current Ratio is ranked higher than
69% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. ZLTQ: 2.87 )
ZLTQ' s 10-Year Current Ratio Range
Min: 1.09   Max: 8.23
Current: 2.87

1.09
8.23
Quick Ratio 2.15
ZLTQ's Quick Ratio is ranked higher than
70% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.12 vs. ZLTQ: 2.15 )
ZLTQ' s 10-Year Quick Ratio Range
Min: 0.78   Max: 7.85
Current: 2.15

0.78
7.85

Valuation & Return

vs
industry
vs
history
Price/Net Cash 60.03
ZLTQ's Price/Net Cash is ranked higher than
85% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZLTQ: 60.03 )
ZLTQ' s 10-Year Price/Net Cash Range
Min: 3.49   Max: 103.21
Current: 60.03

3.49
103.21
Price/Net Current Asset Value 24.14
ZLTQ's Price/Net Current Asset Value is ranked higher than
82% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZLTQ: 24.14 )
ZLTQ' s 10-Year Price/Net Current Asset Value Range
Min: 3.12   Max: 30.64
Current: 24.14

3.12
30.64
Price/Tangible Book 14.39
ZLTQ's Price/Tangible Book is ranked higher than
57% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 6.09 vs. ZLTQ: 14.39 )
ZLTQ' s 10-Year Price/Tangible Book Range
Min: 2.32   Max: 14.86
Current: 14.39

2.32
14.86
Price/Median PS Value 2.39
ZLTQ's Price/Median PS Value is ranked higher than
52% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 1.15 vs. ZLTQ: 2.39 )
ZLTQ' s 10-Year Price/Median PS Value Range
Min: 0.1   Max: 2.63
Current: 2.39

0.1
2.63

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
ZELTIQ Aesthetics Inc is a medical technology company. It develops and commercializes medical products such as 'CoolSculpting System' which is a non-invasive product for the selective reduction of body fat.
» More Articles for ZLTQ

Headlines

Articles On GuruFocus.com
4 Stocks To Buy, 1 To Avoid In 2012 Feb 18 2012 
Weekly CFO Sales Highlight: INFA, DHR, AN, SMTC, ZLTQ Oct 31 2011 

More From Other Websites
Sell in May and go away? Aug 29 2014
RAISE YOUR STOP IN ZELTIQ $ZLTQ Aug 27 2014
Stock Market Video Analysis for Week Ending 8/22/14 Aug 22 2014
ZELTIQ Announces 2014 Investor Day Aug 22 2014
Why ZELTIQ Aesthetics (ZLTQ) Isn't Done Growing Earnings Yet Aug 21 2014
ZELTIQ(R) Exhibiting at Summer AAD 2014 Aug 06 2014
ZELTIQ AESTHETICS INC Financials Aug 05 2014
ZELTIQ to Present at Canaccord Genuity 34th Annual Growth Conference Aug 04 2014
Can the Rally in ZELTIQ (ZLTQ) Shares Continue? Aug 01 2014
Video: Zeltiq Shares Fatten Up On Q2 Profit, Outlook Jul 30 2014
Why Zeltiq Aesthetics (ZLTQ) Stock Hit A Six Month High Today Jul 30 2014
ZELTIQ AESTHETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 29 2014
ZELTIQ Announces Second Quarter 2014 Financial Results Jul 29 2014
Q2 2014 ZELTIQ Aesthetics Inc Earnings Release - After Market Close Jul 29 2014
ZELTIQ Announces Conference Call and Webcast of Second Quarter 2014 Financial Results to Be Held on... Jul 17 2014
Summer's Bare Facts: New Survey Finds That 88 Percent of Women Would Like to Improve One Area of... Jun 25 2014
ZELTIQ AESTHETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement Jun 23 2014
ZELTIQ AESTHETICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 03 2014
Wisconsin Federal Court Rules in Favor of ZELTIQ Aesthetics, Inc. in Case Against Brown Health... Jun 02 2014
ZELTIQ to Participate at Investor Conferences in June 2014 May 27 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK